Accessibility Menu
Envista logo

Envista(NYSE) NVST

Market Cap$4.52BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)+1%
5 Year-32%
1 Year+40%
1 Month+9%
$28.13
-0.07%
-0.02Today
Envista last closing stock price
MetricPriceDate
Last closeUSD 28.152026-08-07
Envista stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.08%USD 27.312026-07-31
1 month+9.36%USD 25.742026-07-08
3 month+16.13%USD 24.242026-05-08
Year to date+29.66%USD 21.712025-12-31
1 year+40.12%USD 20.092025-08-07
3 year-18.22%USD 34.422023-08-08
5 year-31.62%USD 41.172021-08-06
Since inception+0.72%USD 27.952019-09-18

Envista Financials at a Glance

Market Cap

$4.52BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.86B

Net Income (TTM)

$95.00M

EPS (TTM)

$0.58

P/E Ratio

48.91

Dividend

$0.00

Beta (Volatility)

1.03 (Average)

Price

$28.13

Volume

731,433.689

Open

$27.76

Previous Close

$28.15

Daily Range

$27.60 - $28.32

52-Week Range

$18.77 - $30.42

Estimated Earnings Date

Nov 4, 2026

NVST News

Foolcom-Featured.png

Envista Q2 Revenue Jumps 7.7%

Motley Fool Markets TeamAug 5, 2025
GettyImages-1146819254

Better Buy: Align Technology Vs. Envista

David HaenJan 29, 2020
GettyImages-78436359

4 CEOs Who Shaped the 2010s

Lee SamahaNov 29, 2019

NVST: Motley Fool Moneyball Superscore

65

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Envista

Envista makes tools that help dentists fix and clean teeth. These products help people have healthier gums and prettier smiles. Doctors across the world use these supplies every day.

What’s in the Dentist’s Bag?

  • Specialty Products: Surgical implant systems, orthodontic brackets, and removable teeth aligners; generated $457.8 million in sales in the first quarter of 2026.
  • Equipment and Supplies: Digital X-ray systems, office software, and basic tools like drills; earned $247.7 million in sales in the first quarter of 2026.
  • Orthodontic Solutions: Brackets and wires used by specialists to straighten teeth; accounts for a portion of the Specialty Products and Technologies segment.
  • Infection Prevention: Specialized cleaning products and barriers used to keep dental offices safe; included within the Equipment and Consumables segment.

Strategic Growing Pains

  • Acquired Versah LLC in February 2026 for approximately $54.7 million to add specialized bone-compacting dental tools to its portfolio.
  • Authorized a new stock repurchase program in May 2026 to buy back up to $300 million of company shares through 2029.
  • Issued $500.2 million in convertible senior notes in August 2023 to manage existing debt and support corporate operations.
  • Entered a second amended credit agreement in August 2023 to secure revolving credit capacity of up to $750 million.

Global Reach and Innovation

Envista maintains a worldwide presence with research, manufacturing, and sales operations located in more than 30 countries. The company focuses on improving clinical outcomes by providing both high-end surgical technologies and essential everyday dental supplies.

A Look at the Numbers

  • Sales reached $705.5 million in the first quarter of 2026, up 14.4% from the same period in 2025.
  • Net income rose to $38.7 million in the first quarter of 2026, a 115% increase compared to the previous year.
  • Operating income hit $62.5 million in the first quarter of 2026, up 60.3% from the first quarter of 2025.
  • Free cash flow was negative $15.8 million in the first quarter of 2026, which deepened from negative $5.6 million in the prior year period.

Bottom Line

Envista has evolved into a global dental leader by balancing specialized surgical technology with essential office consumables. Its recent acquisition of Versah LLC and focus on clinical innovation support its strategy of expanding in high-growth dental segments.

AI Generated • May 22, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

12,000

CEO

Paul A. Keel, MBA

Website

www.envistaco.com

Headquarters

Brea, CA 92821-6208, US

NVST Financials

Key Financial Metrics (TTM)

Gross Margin

55.50%

Operating Margin

9.92%

Net Income Margin

3.33%

Return on Equity

4.10%

Return on Capital

4.80%

Return on Assets

1697307.53%

Earnings Yield

2.04%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.52BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

160.62M

Volume

731.43K

Avg. Volume

3.16M

Financials (TTM)

Gross Profit

$1.59B

Operating Income

$283.40M

EBITDA

$351.30M

Operating Cash Flow

$299.30M

Capital Expenditure

-$67.00M

Free Cash Flow

$232.30M

Cash & ST Invst.

$1.13K

Total Debt

$1.59K

Envista Performance Analysis

Envista annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,569,100,0002.4%
20232023-12-31USD 2,566,500,000-0.1%
20242024-12-31USD 2,510,600,000-2.2%
20252025-12-31USD 2,719,500,0008.3%
Envista sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-26-1.8%
Q42025-12-3112.0%
Q12026-04-03-6.0%
Q22026-07-033.5%
Envista annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 1.34-27.6%
20232023-12-31USD -0.60N/A
20242024-12-31USD -6.50981.9%
20252025-12-31USD 0.28N/A
Envista sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-26-212.5%
Q42025-12-31211.1%
Q12026-04-0315.0%
Q22026-07-0343.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$730.50M

+7.1%

Gross Profit

$407.00M

+9.9%

Gross Margin

55.72%

N/A

Market Cap

$4.52BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$376.78K

N/A

Employees

12,000

N/A

Net Income

$53.70M

+103.4%

EBITDA

$83.10M

+5.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$1.13K

-100.0%

Total Debt

$1.59K

-100.0%

Accounts Receivable

$436.90

-100.0%

Inventory

$290.90

-100.0%

Long Term Debt

$1.55K

-100.0%

Short Term Debt

$38.50

-100.0%

Return on Assets

16973.08%

N/A

Return on Invested Capital

59167.40%

N/A

Free Cash Flow

$88.50M

+15.8%

Operating Cash Flow

$115.90M

+30.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ICUIICU Medical, Inc.
$184.78+0.12%
CONConcentra Group Holdings Parent, Inc.
$33.60-1.35%
DYNDyne Therapeutics, Inc.
$26.39+0.53%
GRALGRAIL Inc.
$74.43+7.12%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$130.82-0.02%
ACHRArcher Aviation
$6.34+0.13%
INTCIntel
$98.05-0.04%
NVDANvidia
$219.40-0.02%

Questions About NVST

What is the current price of Envista?

Envista is trading at $28.20 per share.

What is the 52-week range for Envista?

Over the past 52 weeks, Envista has traded between $18.77 and $30.42.

How much debt does Envista have?

As of the most recent reporting period, Envista reported total debt of $1.59B.

How much cash does Envista have on hand?

Envista reported $1.13B in cash and cash equivalents in its most recent financial results.

What is Envista’s dividend yield?

Envista does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services